Press release
GLP-1 Analogues Market to Expand to $322.85 Billion by 2034, Experiencing 21.3% CAGR
GLP-1 Analogues Market
Report Scope:
This comprehensive study provides an accurate overview of the worldwide GLP-1 analogues market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by route of administration, product, application, distribution channel, and region in the study, which offers a comprehensive picture of the state of the market.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/glp-1-analogues-market/request-for-sample
Market Definition:
GLP-1 analogues, also known as incretin mimetics, are frequently prescribed for managing type 2 diabetes. This medication functions similarly to a class of hormones known as incretins. GLP-1 analogues alleviate the effects of elevated blood sugar levels. Long-term management of blood sugar levels lowers the chances of encountering complications with the eyes, kidneys, and feet. Many individuals with type 2 diabetes find it helpful that the majority of those using GLP-1 analogues also experience weight loss.
Drivers and Trends:
Elderly individuals have a higher likelihood of developing type 2 diabetes and associated health issues due to age-related factors, thus requiring more GLP-1 analogues inhibitors.
Progress in drug formulations, combined with other antidiabetic medications and better safety profiles, are set to fuel market growth in the forecasted period.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/4115/2
Top Companies:
Because there are so many companies in the market, it is expected to be both competitive and fragmented. Here are the top companies in the GLP-1 analogues market:
AstraZeneca
Bristol-Myers Squibb Company
D&D Pharmatech
Eccogen
Eli Lilly and Company
Glenmark Pharmaceuticals Ltd.
Hanmi Pharm. Co., Ltd.
Lexicon Pharmaceuticals, Inc.
Merck & Co., Inc.
Novo Nordisk A/S
Sanofi
Country-Wise Insights:
According to regional analysis, in 2024, North America held the largest market share. The growing number of people with chronic illnesses has caused a higher need for successful therapies, such as GLP-1 analogues, to manage diabetes and weight.
Also, during the projection period, Asia Pacific is anticipated to register the highest CAGR because of a growing proportion of the elderly demographic.
Segmental Outlook:
By Route of Administration Outlook
Subcutaneous Route
Oral Route
By Product Outlook
Ozempic
Trulicity
Mounjaro
Wegovy
Rybelsus
Saxenda
Victoza
Zepbound
Other Products
By Application Outlook
Type 2 Diabetes Mellitus
Obesity
Others Applications
By Distribution Channel Outlook
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐:
https://www.polarismarketresearch.com/industry-analysis/glp-1-analogues-market
GLP-1 Analogues Market Report Highlights
By product, in 2024, the ozempic segment accounted for the largest revenue share in the GLP-1 analogues market due to its strong efficacy in managing blood glucose levels in individuals affected by type 2 diabetes.
The online pharmacies segment, based on distribution channel, is expected to record a significant CAGR during the forecast period due to expanding internet penetration and competitive pricing strategies.
In 2024, North America accounted for the largest market share due to the high prevalence of type 2 diabetes and obesity.
The Asia Pacific market is expected to record the highest CAGR during the forecast period due to the expanding healthcare access and growing middle-class population.
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Anti-aging Supplements Market
https://elektrotransports.lv/lokali/anti-aging-supplements-market-potential-growth-share-demand-emerging-trends-and-key-player-analysis-2024-2032/357483/
North America Omega 3 Market
https://elektrotransports.lv/lokali/north-america-omega-3-market-analysis-growth-revenue-key-players-regional-trends-and-forecast-2024-2032/357479/
Gluten-free Baking Mixes Market
https://elektrotransports.lv/lokali/gluten-free-baking-mixes-market-size-share-trend-analysis-growth-factors-and-key-vendor-insights-by-2032/357465/
Asia Pacific Energy Drinks Market
https://elektrotransports.lv/lokali/asia-pacific-energy-drinks-market-potential-growth-share-demand-emerging-trends-and-key-player-analysis-2024-2032/357466/
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GLP-1 Analogues Market to Expand to $322.85 Billion by 2034, Experiencing 21.3% CAGR here
News-ID: 3716560 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Pharm
Fenbendazole Market Size, Share and Forecast By Key Players-Jin Dun Pharm, Shand โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Fenbendazole market is anticipated to grow at a compound annual growth rate (CAGR) of 16.05% between 2024 and 2031. The market is expected to grow to USD 68 Billion by 2024. The valuation is expected to reach USD 192.77 Billion by 2031.
The fenbendazole market is experiencing notable growth due to increasing awareness of parasitic infections in bothโฆ
Revolutionizing Revenue: Dexlansoprazole Sustained Release Capsule Market Trends โฆ
Worldwide Market Reports announces the publication of its most recently generated research report titled, "Dexlansoprazole Sustained Release Capsule Market - Forecast to 2030", which offers a holistic view of the Dexlansoprazole Sustained Release Capsule market through systematic segmentation that covers every aspect of the target market. Dexlansoprazole Sustained Release Capsule with 100+ market data Tables, Pie Chat, Graphs, and Figures spread through Pages and easy-to-understand detailed analysis. The information isโฆ
Paromomycin Sulfate Market 2030 by Top 10+ Players Pfizer,, Changrui Pharm,, ERF โฆ
Paromomycin Sulfate is an antibiotic used to treat infections caused by certain parasites. It is commonly used to treat visceral leishmaniasis, a serious parasitic disease that affects the internal organs. The market for Paromomycin Sulfate is relatively small compared to other antibiotics, as it is primarily used to treat a specific type of parasitic infection. However, the market for Paromomycin Sulfate is expected to grow as the incidence of visceralโฆ
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin โฆ
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunitiesโฆ
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 โฆ
Global โClopidolโ Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendationsโฆ
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 โฆ
The new study on the Global โParomomycin Marketโ 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at theโฆ
